Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Palleon Pharmaceuticals Presents First-in-Class B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting
-
LRT Company Fully Subscribes $20.55 Million All-Cash, Ground-Lease Based DST Offering Near Providence, Rhode Island
-
Leonardo DRS Launches New Maritime Counter-UAS Capability to Defeat Aerial Unmanned Threats at Sea
-
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
-
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
-
Homebuyers Hold the Negotiating Power In 38 Major Metros, Up From 29 Last Year
-
Blue Cross Blue Shield of Massachusetts to Provide Free Bluebikes Credits for Earth Week
-
Argo Biopharma Doses First Patients in Phase II Clinical Trials of siRNA Therapy BW-40202
-
Stensul Launches Bring Your Own LLM, Enabling Customers to Run Their Own LLM Inside a Governed Workflow
-
Vizient Showcases Integrated Supply Chain Capabilities at Spring IDN to Strengthen Trust in Healthcare Performance
-
Motorola Solutions Redefines Crime Center Operations, Centering Workflows Around Measurable “Missions”
-
LightSpun Names Healthcare Growth Veteran Bill Henderson as Strategic Advisor to the CEO, Accelerating National Expansion
-
Mammoth Announces First-Quarter 2026 Conference Call
-
CROSS TIMBERS ROYALTY TRUST DECLARES APRIL CASH DISTRIBUTION
-
Exchange Solutions Puts a Data Scientist in Every Loyalty Marketer's Hands
-
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
-
C1 Fund Inc. (NYSE: CFND) Announces Liquidity Event from Ripple Investment, Realizing Approximately 150% Return in Less than Four Months
-
Aptean introduces AI platform and AI agents for Business Central On-Premises Customers
-
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor
-
Shane Miller, CFP®, CRPS®, CEPA®, Joins Prime Capital Financial
-
CMP Pharma Announces Availability of a New Alcohol-Free Reformulation of Norliqva® (Amlodipine) Oral Solution
-
Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview
-
Trading Technologies' Nick Garrow Assumes New Role of Chief Strategy Officer; Josh Monroe Joins as Chief Revenue Officer
-
MOLECULE Launches Enhanced Reflex Collection, Showcasing Recovery at the Boston Marathon
-
INBRAIN Neuroelectronics Completes Enrolment of World’s First-in-Human Study of Graphene Neural Interfaces for Brain Decoding & Mapping
-
Diversified Appoints Tyler Affolter as Chief Revenue Officer to Support Next Phase of Growth
-
Toshiba Honors Earth Day 2026 Throughout the Year
-
Integrated Data Services Achieves CMMC 2.0 Level 2 Certification, Reinforcing Commitment to Protecting Defense Data
-
Experian Teams With TazWorks to Enable Faster Hiring With Instant Employment Verification
-
o9 Selected by Chow Tai Fook Jewellery Group to Optimize Data-Driven Retail Planning
-
Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income
-
Dynex Capital, Inc. Announces First Quarter 2026 Results
-
KBRA Releases Research – European CLO Manager Style Comparisons: April 2026 Update
-
Four Seasons Resort Palm Beach Appoints Mark Bingle as General Manager
-
Bill Nye ‘The Science Guy’ Joins Arbor Day Foundation Podcast In Latest Episode
-
TTP Group Announces the Sale of LEX Diagnostics
-
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
-
X-Bow Debuts In-House Electronic Ignition Safety Device at Sea-Air-Space
-
Prepayments, Realkredit Danmark A/S
-
Karsan Autonomous e-ATAK Became One of the First Autonomous Public Transportation Applications in Ski Tourism!
-
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
-
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
-
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
-
New Book Reexamines Controversial 19th-Century Surgery and Its Legacy in Women's Health Care
-
RIWI Announces Planned Board Transition and Appointment of New Directors
-
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
-
GMG's Graphene Engine Oil Additive G(R) LUBRICANT: Patent Granted in USA; Allowed in China
-
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
-
Digi Power X Signs First AI Revenue Contract - $19.6 Million, 24-Month SubQ AI Agreement, Validating Operational Launch of AI Factory
-
Caledonia Mining Corporation Plc Blanket Mine Q1 2026 Production and Operating Update

